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Summary
 Hypertension is the most common chronic disease 
among people aged 15 years or above in Hong Kong. 
It is the second commonest reason for consultation 
i n p r i m a r y c a r e .  T h e R e f e r e n c e F r a m e w o r k f o r 
Hypertension Care for Adults in Primary Care Settings 
was publ ished by the Task Force on Conceptua l 
Model and Preventive Protocols of the Working Group 
on Primary Care in 2010 in order to translate medical 
research evidence into health benefit of our population. 
I t is a consensus document endorsed by var ious 
stakeholders including patient groups and primary care 
doctors and considered to be the most appropriate 
and feasible application of evidence to Hong Kong’s 
primary care. This article discusses how the family 
doctor can translate the Framework recommendations 
on hypertension management into daily practice. It is 
believed that adoption of the reference framework can 
lead to more effective management of this common 
chronic condition in primary care settings.
摘要
 高血壓是15歲或以上香港人最常見的慢性疾病，也
是基層醫療中的第二種最常見診症原因。為將醫學研究結
果轉化成病人的健康效益，基層醫療概念模式和預防工作
常規專責小組在2010年出版了治理成年人高血壓的參考
概覽。這份文獻的制訂得到各方面人仕的共識，其中包括
病人團體和基層醫療醫生的利益相關者。它被認為是在香
港基層醫療最合適和可行的做法。本文論述家庭醫生可以
如何將參考概覽中的建議應用在日常高血壓的預防及治療
上。我們認為參考概覽的採用能在基層醫療更有效地處理
這常見的慢性病。
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Introduction
	 Hypertension	 is	 the	 commonest	 chronic	 disease	 in	
Hong	Kong	with	 a	 prevalence	 of	 27%	 among	 people	
aged	 15	 years	 or	 above.1	 It	 is	 the	 second	 commonest	
reason	 for	 consultation	 in	 primary	 care.2	 The	 evidence	
on	 the	 association	 between	 high	 blood	 pressure	 and	
premature	 death	 and	 stroke	 has	 been	 known	 since	 the	
publication	 of	 the	 Society	 of	Actuaries	 study	 on	 body	
build	 and	 blood	 pressure	 in	 1959.3	 Tens	 of	 thousands	
of	 research	 studies	 confirmed	 the	 harm	of	 hypertension	
and	 the	 benefit	 of	 treatment	 to	 lower	 blood	 pressure.	
The	 Prospective	 Study	 Collaboration	 (PSC)	 meta-
analysis	 of	 over	 a	million	 subjects	 from	 61	 studies	
concluded	 that	 at	 all	 blood	 pressure	 levels	 down	 to	
115/75	 mmHg,	 a	 10mmHg	 systolic	 blood	 pressure	
(SBP)	 or	 a	 5mmHg	 diastolic	 blood	 pressure	 (DBP)	
reduction	 is	 associated	with	 a	 40%	 and	 30%	 relative	
risk	 reduction	 (RRR)	 in	 stroke	 and	 other	 vascular	
mortalities	 respectively.4	 	 Other	 studies	 have	 shown	
that	 a	 reduction	 of	 as	 little	 as	 2	mmHg	 in	DBP	 could	
reduce	 cardiovascular	 complications	 significantly.5	
Many	 drugs	 have	 been	 shown	 to	 be	 e f fec t ive	 in	
lowering	blood	pressure	and	reduction	of	cardiovascular	
complications.6,7	 	
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	 Translation	 of	 medical	 research	 evidence	 into	
health	 benefit	 of	 the	 population	 is	 always	 a	 challenge.	
Wilber	and	Barrow	described	 the	“rule	of	halves”	 in	 the	
rates	of	detection,	 treatment	and	control	of	hypertension	
were	 all	 around	 50%	 among	 the	 relevant	 populations	
in	 the	U.S.	 in	 1972,8	which	was	 later	 also	 observed	 in	
many	 other	 populations.9,10	 The	Hong	Kong	 Population	
Health	 Survey	 2003-2004	 found	 that	 only	 44.5%	 of	
those	 with	 high	 blood	 pressure	 were	 diagnosed.1	 A	
survey	on	 the	management	of	hypertension	among	 local	
primary	 care	 doctors	 found	 that	 only	 30%	would	 start	
treatment	 for	 patients	with	 blood	 pressure	 >140/90	 and	
the	 control	 targets	 of	 SBP	 <140	 and	DBP	 <90	were	
adopted	 by	 only	 26%	 and	 47%	 of	 the	 surveyed	 doctors	
respectively.11
	 To	 promote	 bes t	 p rac t ice ,	 the	 Wor ld	 Hea l th	
Organisation	 (WHO)12	 and	many	 overseas	 national	
professional	 bodies	 have	 developed	 guidelines	 on	
the	 treatment	 of	 hypertension.7,	 13,	 14	 Similar	 initiative	
was	 also	 called	 for	 to	 assure	 the	 quality	 of	 care	 of	
hypertension	for	our	population	in	Hong	Kong.11	 	 	 	 	
The Hong Kong Reference Framework 
	 Th e	 Hong	 Kong	 Re f e r e n c e	 F r amewo rk	 f o r	
Hypertension	Care	 for	Adults	 in	 Primary	Care	 Settings,	
which	 i s	 ava i l ab le	 on l ine	 (www.fhb .gov .hk	 and	
www.pco.gov.hk),15	 was	 first	 published	 in	 2010	 to	
address	 the	 needs	 of	 our	 local	 practice,	 and	 is	 being	
updated	 regularly.	 It	 is	 a	 consensus	 document	 endorsed	
by	 various	 stakeholders	 including	 patient	 groups	 and	
primary	 care	 doctors	 and	 is	 considered	 to	 be	 the	most	
appropriate	 and	 feasible	 application	 of	 evidence	 to	
Hong	Kong’s	 primary	 care.	 The	 framework	 consists	 of	
a	 core	 document	 and	 eight	modules.	 Summary	 of	 the	
hypertension	reference	framework	is	shown	in	Figure 1.
	 The	 core	 document	 describes	 the	 principles	 of	 the	
management	 of	 hypertension	 from	 primary	 prevention	
to	 patient	 empowerment	 for	 self-management,	 and	
makes	 evidence-based	 recommendations	 for	 practice	 as	
summarized	in	Table 1.	 	 	
Translating research evidence into daily practice
	 The	 commi tment	 o f	 bo th	 pub l ic	 and	 p r iva te	
primary	 care	 doctors,	 to	 the	 prevention,	 detection	 and	
management	 of	 adults	with	 hypertension	 is	 of	 primary	
importance.	We	 need	 to	 assure	 the	 public	 that	 primary	
care	 doctors	 have	 the	 needed	 competence	 and	 support	
services	to	manage	hypertension	to	a	high	standard.	 	 	 	
Prevention	&	Screening	of	Hypertension	
	 Every	 primary	 care	 consultation	 is	 an	 opportunity	
for	 preventing	 and	 screening	 hypertension.	 People	 in	
Hong	Kong	 consult	 primary	 care	 an	 average	 of	 8	 times	
a	year	and	80%	of	 the	population	would	have	consulted	
primary	 care	 at	 least	 once	 within	 a	 year16,17	 which	
provides	 plenty	 of	 opportunities	 for	 doctors	 “to	 advise	
individuals	 at	 increased	 risk	of	 developing	hypertension	
and	 patients	 with	 hypertension	 to	maintain	 optimal	
body	weight,	 restrict	dietary	salt,	abstain	 from	smoking,	
and	 pract ise	 heal thy	 l i fes tyles”,	 and	 to	 carry	 out	
opportunistic	 blood	 pressure	measurement	 for	 all	 adults	
aged	 18	 or	 above.15	 Classification	 of	 blood	 pressure	
and	 recommendations	 for	 frequency	 of	 blood	 pressure	
screening	is	summarized	in	Table 2.13
	 To	 ensure	 efficient	 service	 delivery	 to	 all	 eligible	
patients,	 a	 system	 for	 identifying	 eligible	 patients,	
accura te	 b lood	 pressure	 measurement	 (Module	 2	
of	 Reference	 Framework),	 counseling	 on	 lifestyle	
modifications,	 recalling	 high-risk	 patients,	 and	 proper	
record	 keeping	 must	 be	 incorporated	 into	 routine	
practice.	 There	 should	 be	 an	 agreed	 protocol	 among	
primary	 care	 team	members	 on	who,	when,	what	 and	
how	 various	 tasks	 are	 to	 be	 carried	 out.	 The	medical	
record	must	 provide	 continuous	 recording	 and	 promote	
easy	 retrieval	 of	 blood	 pressure	measurements	 as	well	
as	 data	 on	 lifestyle,	 health	 advice,	 cardiovascular	 risk	
factors	 and	 other	 relevant	 parameters.	An	 illustration	
o f	 a	 supp l emen ta ry	 r eco rd	 shee t	 o r	 modu le	 fo r	
hypertension	care	is	shown	below	(Figure 2).	 	 	 	 	
	 To	 serve	 the	purpose,	dietary	 and	physical	 exercise	
advice	 needs	 to	 be	 very	 specific	 (Modules	 5	 and	 6	 of	
the	Reference	 Framework).15	 Repeated	 counseling	 and	
coordinated	 input	 from	 different	 health	 professionals	
including	 dieticians,	 physiotherapists	 (for	 exercise	
counseling),	 nurses	 from	 smoking	 cessation	 counseling	
clinic,	 are	 needed	 to	 enhance	 the	 effectiveness	 of	
var ious	 preventive	 advice. 16,	 18	 I t	 cannot	 be	 over-
emphasized	that	screening	of	hypertension	is	worthwhile	
only	 if	 patients	 with	 suboptimal	 BP	 are	 adequately	
reviewed	 in	 order	 to	 establish	 the	 diagnosis	 and	 to	
provide	 appropriate	 treatment.	 Hypertension	 should	
confirm	 if	 blood	pressure	 is	 persistently	high	 in	 at	 least	
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Figure 1: One-page summary of the Hong Kong Reference Framework for Hypertension Care for Adults in 
Primary Care Settings
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Table 1:  Recommendations of the Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care 
Settings15
Prevention of Hypertension – Adoption of a Healthy Life Style
1	 Advise	 individuals	 at	 risk	 of	 developing	 hypertension	 and	 patients	with	 hypertension	 to	maintain	 optimal	 body	weight,	 restrict	 dietary	 salt,	
abstain	from	smoking,	and	practise	healthy	lifestyles.	
Early Identification of People with Hypertension
2	 Opportunistic	 blood	 pressure	measurement	 in	 all	 adults	 from	 18	 years	 of	 age	 at	 least	 every	 2	 years,	with	 appropriate	 follow	 up	 actions	
according	to	blood	pressure	results
	 •	 BP120-139/80-89	mmHg:	re-check	1	year	+	lifestyle	
	 •	 BP140-159/90-99	mmHg:	confirm	within	2	months	+	lifestyle	
	 •	 BP160-179/100-109	mmHg:	evaluate	within	1	month	+	lifestyle,	and	drug	treatment	if	high	blood	pressure	is	confirmed.
	 •	 BP>180/110	mmHg:	further	evaluation	within	1	week+	lifestyle,	and	drug	treatment	if	high	blood	pressure	is	confirmed.	 	
Management of Adults with Hypertension
3	 Initial	comprehensive	assessment	for	co-existing	cardiovascular	risk	factors	or	other	problems	that	may	affect	prognosis	and	treatment
	 •	 Cigarette	smoking
	 •	 Obesity
	 •	 Physical	 inactivity
	 •	 Dyslipidaemia
	 •	 Diabetes	mellitus
	 •	 Microalbuminuria	or	estimated	GFR	<	60	ml/min
	 •	 Age	(older	than	55	for	men,	65	for	women)
	 •	 Family	history	of	essential	hypertension	and	premature	cardiovascular	disease	(men	under	55	or	women	under	65)
4	 Adoption	of	a	healthy	lifestyle	with	the	following	modifications
 • Encourage overweight (BMI ≥ 23) and obese (BMI ≥ 27.5) hypertensive patients to lose weight
	 •	 Increase	consumption	of	fruits	and	vegetables	to	5	portions	per	day,	and	reduce	total	and	saturated	fat	consumption
	 •	 Reduce	salt	 intake	to	less	than	5	g	(around	1	teaspoon	of	table	salt)	per	day	and	not	to	use	added	salt.
	 •	 Increase	 level	of	physical	activity	and	take	regular	exercises	(	aerobic	exercise	 	>30	min	per	day	and	resistance	exercise	 	8-10	sets	at	8-12	
repetitions	per	set	2-3	times	per	week).	
	 •	 Reduce	alcohol	intake	to	no	more	than	two	drinks	per	day	for	men	and	1	drink	per	day	for	women
	 •	 Encourage	to	stop	smoking	and	refer	to	smoking	cessation	services	if	needed.
5 Start drug treatment in patients with sustained BP ≥ 140/90 mmHg despite lifestyle modification or if target organ damage is present.  Start 
with	 angiotensin	 converting	 enzyme	 inhibitor	 (ACEI)	 /	Calcium	Channel	Blocker	 (CCB)	 /	 thiazide	 diuretic,	 switch	 if	 there	 is	 side	 effect,	 add	
if	 inadequate	BP	control.
6	 Goal	of	 therapy	for	simple	hypertensive	patients	 is	<140/90	mmHg,	and	<130/80	mmHg	for	patients	with	hypertension	and	diabetes	or	chronic	
kidney	diseases	respectively.
7	 Regular	follow	up	after	 initiating	antihypertensive	drug	treatment
	 •	 Every	2	weeks	until	 blood	pressure	goal	 is	 achieved.	More	 frequent	 visits	may	be	 indicated	 for	 patients	with	BP	160/100	mmHg,	or	with	
complications.	
	 •	 Every	6-12	weeks	after	blood	pressure	goal	 is	achieved
	 •	 Annual	 assessment	of	 	 lifestyle,	 drug	adherence	 and	 side	 effects,	 family	history	of	premature	 coronary	heart	 diseases,	BMI,	urine	protein,	
renal	function,	 lipid	profile,	and	fasting	blood	sugar	
8	 Referrals	 to	hospital	or	specialists	are	indicated	for	the	following	patients
	 Immediate	referral	 to	hospital	
	 •	 Malignant	hypertension	
	 •	 Accelerated	hypertension	DBP	>130mmHg	and	retinal	haemorrhage
	 •	 Persistent	BP	>220/120	mmHg	despite	rest	or	drug	treatment
	 •	 Pregnancy	and	BP	140/90	mmHg	and	>20	weeks	gestation,	or	signs	and	symptoms	of	pre-eclampsia
	 Referral	 to	specialists
	 •	 Suspected	secondary	hypertension
	 •	 Patients	aged	30	or	below
	 •	 Hypertension	in	pregnancy	<	20	weeks	gestation	without	signs	or	symptoms	of	pre-eclampsia.	
	 •	 Patients	with	progressive	complications
	 •	 Medication	problems	such	as	severe	drug	reaction,	 treatment	resistance,	multiple	drug	intolerance,	or	multiple	drug	contraindications
Adapted from the Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care Settings15
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Table 2: Classification of blood pressure and recommendations for frequency of blood pressure screening (Adapt from 
the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure) 13
Blood  Initial Blood Pressure   Recommended minimum review  Action
pressure  (mmHg)	Note	2  period Note	3
classification Note	1  	 	 	
	 	 Systolic Diastolic 	
Normal	 <120	 <80	 Recheck	in	2	years	 Encourage	to	adopt	
	 	 	 	 (annual	check	for	adult	 	 healthy	lifestyle
	 	 	 	 aged>75	years)	
Pre-	hypertension	 120-139	 80-89	 Recheck	in	1	year	 Lifestyle	modification
Stage	I	hypertension	 140-159	 90-99	 Confirm	within	2	months	Note	4	 Lifestyle	modification
Stage	II	hypertension	 160-179	 100-109	 Evaluate	within	one	month	 •	 Treat	within	one	month
	 	 	 	 	 •	 Lifestyle	modification
	 	 >180	 >110	 Further	evaluation	within	one	week	 •	 I f 	 h i gh	 b lood	 p r e s su r e	 i s	
confirmed,	 drug	 t reatment	
should	be	commenced	
	 	 	 	 	 •	 May	warrant	 urgent	 referral	
if	 patient	 presents	 features	
s u g g e s t i v e 	 o f 	 m a l i g n a n t	
hypertension	(Refer	to	Box	2)
	 	 	 	 	 •	 Lifestyle	modification	
Note 1. The classification is based on the average of 3 or more properly measured seated blood pressure readings, at least 1 week apart on office visits.21
Note 2. If systolic and diastolic categories are different, follow recommendations for shorter review period.
Note 3. Modify review period according to reliable information about past blood pressure measurements, other cardiovascular risk factors, or target organ 
diseases.
Note 4.  Updated NICE guideline in August 2011.7 If the clinic blood pressure is 140/90 mmHg or higher, offer ambulatory blood pressure monitoring (ABPM) 
to confirm the diagnosis of hypertension. If a person is unable to tolerate ABPM, home blood pressure monitoring (HBPM) is a suitable alternative to 
confirm the diagnosis of hypertension. When using ABPM to confirm a diagnosis of hypertension, ensure that at least two measurements per hour are 
taken during people’s usual waking hours (for example, between 08:00 and 22:00). Use the average value of at least 14 measurements taken during the 
person’s usual waking hours to confirm a diagnosis of hypertension. When using HBPM to confirm a diagnosis of hypertension, ensure that: for each 
blood pressure recording, two consecutive measurements are taken, at least 1 minute apart and with the person seated and blood pressure is recorded 
twice daily, ideally in the morning and evening and blood pressure recording continues for at least 4 days, ideally for 7 days. Discard the measurement 
taken on the first day and use the average value of all the remaining measurements to confirm a diagnosis of hypertension.
3	 properly	measured	 seated	 blood	 pressure	 readings,	
each	 at	 least	 1	week	 apart	 during	 office	 visits.	 People	
with	BP	 >180/110	mmHg	 should	 be	 further	 evaluated	
within	 1	week;	 those	with	 levels	 of	 160-179/100-109	
mmHg	 should	 be	 evaluated	 again	 within	 1	 month;	
while	 those	with	 levels	of	140-159/90-99	mmHg	should	
be	re-checked	within	2	months	to	confirm	the	diagnosis,	
in	 addition	 to	 providing	 lifestyle	 advice	 (Table 1).15	
Med i c a l 	 r e co r d s	 o f 	 p a t i e n t s 	 w i t h	 r a i s ed	 b l ood	
pressure	 should	 be	 flagged	 for	 repeat	 blood	 pressure	
measurements.	 Furthermore	 the	 practice	 should	 set	 up	
a	 recall	 system	 to	 remind	 patients	 due	 for	 follow	 up.	
24-hour	 ambulatory	 blood	 pressure	monitoring	 (ABPM)	
and	home	blood	pressure	monitoring	 (HBPM)	 for	 seven	
consecutive	days	are	suitable	alternatives	for	confirming	
the	 diagnosis	 of	 hypertension.7	 A	modeling	 study	 in	
the	United	Kingdom	 suggested	 that	 24-hour	 ambulatory	
blood	 pressure	may	 be	 the	most	 cost-effective	method	
for	 d iagnos ing	 hyper tens ion19	 bu t	 i t	 needs	 to	 be	
confirmed	 by	 empirical	 clinical	 studies	 before	 it	 can	 be	
recommended	as	a	routine	practice.	
Management	of	Adults	Hypertension	
	 Patients	 confirmed	 to	 have	 hypertension	 should	
be	 evaluated	 for	 possible	 secondary	 hypertension,	 co-
existing	 cardiovascular	 risk	 factors,	 or	 target	 organ	
damage	 (Table 1 ) .	 The	 deta i ls	 for	 evaluat ion	 on	
possible	 secondary	 hypertension	 and	 target	 organ	
damage	 assessment	 have	 been	 described	 in	Module	
3 	 a n d 	 Modu l e 	 4 	 o f 	 t h e 	 R e f e r e n c e 	 F r amewo r k	
respectively.15	 To	 achieve	 this,	 direct	 access	 to	 reliable	
and	affordable	investigation	services	is	essential.	 	 	
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	 The	 treatment	of	hypertension	starts	with	 lifestyle	
modif ica t ions	 s imi lar	 to	 those	 recommended	 for	
prevention,	 therefore	 support	 from	 relevant	 multi-
d isc ip l inary	 serv ices	 i s	 necessary .	 Pa t ients	 wi th	
ma l ignan t	 hype r t ens ion	 (DBP	 >	 130	 and	 heavy	
prote inur ia ,	 papi l loedema	 or	 encephalopathy)	 or	
acce lera ted	 hyper tens ion	 (DBP	 >	 130mmHg	 and	
retinal	 hemorrhage)	 should	 be	 referred	 to	 the	 hospital	
immedia te ly .	 Drug	 t r ea tment	 shou ld	 be	 s t a r t ed ,	
i f	 	 hyper tens ion	 i s	 conf i rmed ,	 wi th in	 one	 week	
for	 patients	 with	 blood	 pressure	 >180/110	 mmHg,	
within	 one	month	 for	 patients	 with	 blood	 pressure	 of	
160-179/100-109	mmHg,	 and	 for	 those	with	 sustained	
b lood	 pressure	 o f	 140-159/90-99	 mmHg	 desp i te	
l ifestyle	 modifications	 for	 6	 months.	 Angiotensin	
conve r t i ng	 enzyme	 i nh ib i t o r s	 (ACEI ) , 	 c a l c i um	
channel	 blockers	 (CCB),	 and	 thiazide	 diuretics	 are	
recommended	 as	 first-line	 drugs	 for	 hypertension.	
Beta	blockers	 are	no	 longer	 recommended	as	 first	 line	
drugs	 for	 uncomplicated	 hypertension.	 The	 choice	
of	 d rug	 needs	 to	 be	 ind iv idua l ized	 accord ing	 to	
    
    HT  Initial Assessment HT  Follow up Assessment
Lens	&	Fundi	 	 	 	 	 	 	 	
Peripheral	Pulse	 	 	 	 	 	 	 	
Cardiovascular	Examination	 	 	 	 	 	 	
Fasting	Blood	Sugar	 	 	 	 	 	 	 	
Renal	Function	Test	 	 	 	 	 	 	
Urine	for	protein	/	albumin	 	 	 	 	 	 	
Lipids	 	 	 	 	 	 	 	
ECG	 	 	 	 	 	 	
Drugs	Regimen	 	 	 	 	 	 	
Others	 	
Figure 2:  Example of Medical Record Template for Continuing Health Assessment and Hypertensive Care
Health Assessment Chart -All Adults 
Date		 	 	 	 	 	 	 	 	 	
Family	History			 	 	 	 	 	 	 	 	
Weight	 	 	 	 	 	 	 	 	 	 	
Height	 	 	 	 	 	 	 	 	 	 	
BMI		 	 	 	 	 	 	 	 	 	
B.P.	 	 	 		 	 	 	 	 	 	 	 	
Drinking		 	 	 	 	 	 	 	 	 	
Smoking		 	 	 	 	 	 	 	 	 	
Exercise	 	 	 	 	 	 	 	 	 	 	
Diet	 	 	 	 	 	 	 	 	 	 	
Others		
other	 patient	 characteristics,	 e.g.	 diuretics	 should	 be	
avoided	 in	 patients	 with	 co-existing	 gout.	 A	 detailed	
description	 of	 the	 different	 anti-hypertensive	 drugs	 is	
described	 in	Module	 7	 of	 the	 reference	 framework.15	
Since	 some	 patients	 may	 be	 reluctant	 to	 commit	 to	
life-long	 anti-hypertensive	 drug	 treatment,	 continuing	
follow	 up	 and	motivational	 counseling	 by	 the	 family	
doctor	 would	 be	 helpful.	 A	 treatment	 algorithm	 is	
illustrated	 in	Figure 3.
	 Patients	 should	 be	 followed	 up	 two	weekly	 after	
init iat ion	 of	 drug	 treatment	 unti l	 the	 target	 blood	
pressure	 is	attained,	after	which	 the	follow-up	intervals	
can	be	 increased	 to	8-12	weeks.	
	 Over	 90%	 of	 the	 adult	 patients	 with	 hypertension	
can	 be	 managed	 exclus ive ly	 in	 pr imary	 care	 but	
r e f e r r a l 	 t o 	 s p e c i a l i s t s 	 f o r 	 f u r t h e r 	 managemen t	
i s 	 r e commended	 f o r	 p a t i en t s 	 w i t h	 h i gh	 r i s k	 o f	
complications	 or	 features	 suggestive	 of	 secondary	
hypertension	(Table 1).	
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The family doctor  
	 Local	 research	 has	 shown	 that	 having	 a	 regular	
family	 doctor	 is	 associated	with	 a	 higher	 likelihood	
of	 blood	 pressure	 screening	 and	 	 healthy	 lifestyle.20	
The	 family	 doctor’s	 emphasis	 on	 a	 continuing	 trusting	
doctor-patient	relationship	and	person-centred	care	is	the	
key	 to	 the	 appropriate	 translation	 of	 recommendations	
into	 individualized	 management.	 However,	 family	
doctors	 are	 only	 part	 of	 the	 larger	 health	 care	 delivery	
system,	 the	 proper	 function	 of	which	 requires	 the	 co-
ordinated	 input	 from	 different	 partners	 including	
patients,	 the	 government,	 specialists,	 academia,	 other	
health	 professionals,	 laboratories,	 community	 services.	
The	public	 and	medical	profession	need	 to	make	a	 joint	
effort	 to	prevent,	detect	and	manage	hypertension	better	
in	Hong	Kong	to	break	the	“rule	of	halves”.8	n
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Compelling	
indication	/	
contraindication	
over	choice	of	drug
Start	with	either	ACEI	(or	ARB	if	ACEI	intolerant),	
calcium	channel	blocker	or	thiazide-type	diuretic
No	response	or	not	 tolerated,	switch	to	another	drug.	
Inadequate	response	but	tolerated,	add	a	second	drug	
from	different	class
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Refer	to	specialist	 if	blood	pressure	still	not	under	
control
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Appendix 1: Compelling and Possible Indications and Contraindications for the Major Classes of Antihypertensive Drugs
Class of Drug Compelling Indications Possible Indications Compelling Contraindications Possible Contraindications
ACE	Inhibitors	(ACEI)	 Heart	failure,	 	 Proteinuria	renal	disease	 Pregnancy,	Bilateral	renal	 	 Renal	impairment
	 	 Left	ventricular	dysfunction,	 	 artery	stenosis,	 	 	 Close	monitoring	of	
	 	 Post	myocardial	 infarction,	 	 Hyperkalaemia	 electrolyte	and	
	 	 Diabetic	nephropathy	 	 	 	 creatinine	level	needed
Angiotensin	II	Receptor	 	 ACE	inhibitor	intolerance	 	 Pregnancy,	Bilateral	renal	 	 Renal	impairment
Blockers	(ARB)	 	 	 	 artery	stenosis,	Hyperkalaemia		 Close	monitoring	of	
	 	 	 	 	 	 	 electrolyte	and	creatinine		 	
	 	 	 	 	 	 	 level	needed
Alpha-Blockers	 Benign	prostatic	hypertrophy		 	 	 	 	 Orthostatic	hypotension
Beta-Blockers	 	 Angina,	Post	myocardial	 	 Heart	failure	 Asthma,	chronic	obstructive		 Peripheral	vascular	 	 	
	 	 infarction	Tachyarrhythmias	 (Metoprolol	succinate	 pulmonary	disease,	 disease
	 	 	 	 sustained	releasing,	 	 Heart	block
	 	 	 	 Bisoprolol,	and		
	 	 	 	 Carvedilol	at	medium	
	 	 	 	 to	high	dose)a	
Calcium	Channel	Blockers	 Elderly	patients,	 Peripheral	vascular	disease	 	 	 Congestive	heart	failure
(dihydropyridine)	 Isolated	systolic	hypertension
	
Calcium	Channel	Blockers	 Angina	 	 Heart	block	 Congestive	heart	
(rate	limiting,	e.g.	verapamil,	 	 	 	 	 	 	 failure,	combination	
diltiazem)	 	 	 	 	 	 with	beta-blockers
Thiazide	/	 thiazide-	 Heart	failure,	 	 Gout	 	 Dyslipidaemia,	Pregnancy,
like	Diuretics	 Elderly	patients,	 	 	 	 Sexually	active	males	
	 	 Isolated	systolic	hypertension
a.  Metoprolol succinate slow release, bisoprolol and carvedilol were shown by RCT to be beneficial in patients with heart failure. 
